BWS is a questionable disease in the field of genetic metabolism, clinical performance is complex and often involves multi-system congestion. Early identification and normalisation of the disease are essential for improving prognosis. Diagnosis of the disease requires a combination of clinical performance, imaging inspection, laboratory testing and pathological activation.
The platform can assist in linking teams of authoritative experts at home and abroad to provide accurate diagnosis and treatment programs. Treatment and management of BWS requires the development of a multi-dimensional treatment plan, which typically includes drug therapy, rehabilitation interventions, regular follow-up, and so on. In recent years, with the development of therapeutic, immune-regulatory therapy and precision medicine, many previously difficult to treat genetic metabolic disorders have been significantly improved.
Treatment requires close monitoring of therapeutic effects and adverse reactions and timely adjustment to changes in the course of the disease. Multidisciplinary collaboration (MDT) is particularly important for the integrated management of BWS. The platform serves the China International Medical Service System, a team of nationally and internationally authoritative experts in the field of genetic metabolism who provide the following services to patients: 2.
Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.